Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 26,493 | 17,472 | 18,568 | 19,243 | 15,342 |
| Cost of Goods | 18,552 | 13,602 | 10,919 | 10,587 | 8,479 |
| Gross Profit | 7,941 | 3,869 | 7,649 | 8,656 | 6,863 |
| Operating Expenses | 10,133 | 10,220 | 10,867 | 8,986 | 8,723 |
| Operating Income | -1,640 | -5,748 | -2,299 | 257 | -1,380 |
| Other Income | -506 | -22 | -187 | -327 | 348 |
| Pre-tax Income | -2,147 | -5,770 | -2,486 | -69 | -1,032 |
| Income Tax | 10 | 5 | 8 | 9 | -10 |
| Net Income Continuous | -2,157 | -5,775 | -2,494 | -78 | -1,022 |
| Net Income | $-2,157 | $-5,775 | $-2,494 | $-78 | $-1,022 |
| EPS Basic Total Ops | -0.26 | -0.75 | -0.32 | -0.01 | -0.14 |
| EPS Basic Continuous Ops | -0.26 | -0.75 | -0.32 | -0.01 | -0.14 |
| EPS Diluted Total Ops | -0.26 | -0.75 | -0.32 | -0.01 | -0.14 |
| EPS Diluted Continuous Ops | -0.26 | -0.75 | -0.32 | -0.01 | -0.14 |
| EPS Diluted Before Non-Recurring Items | -0.26 | -0.75 | -0.32 | -0.01 | -0.14 |
| EBITDA(a) | $1,090 | $-3,009 | $196 | $2,726 | $1,070 |